Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;7(4):1310-1313.e2.
doi: 10.1016/j.jaip.2018.07.008. Epub 2018 Jul 23.

Elevation in histamine and tryptase following exercise in patients with mastocytosis

Affiliations

Elevation in histamine and tryptase following exercise in patients with mastocytosis

Joseph M Kulinski et al. J Allergy Clin Immunol Pract. 2019 Apr.

Abstract

Patients with mastocytosis exhibit an increase in serum levels of mast cell-related mediators with exercise and therefore should be guided regarding management of mast cell-associated symptoms to improve safety and quality of life.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest statement

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

Figures

FIGURE 1.
FIGURE 1.
The effect of exercise on serum histamine and tryptase levels in patients with mastocytosis. A, Exercise challenge depicting blood draws (1 - 7). B, Mean ± SE change in serum histamine from baseline (time point 1) at time points 2 - 7. C, Baseline and peak post-exercise serum histamine levels (mean ± SE for each group). Same for tryptase (D,E). Data was derived from 3 technical replicate measurements at each time point. NV - Normal volunteer, CU - Cholinergic urticaria patient, ISM - Indolent systemic mastocytosis patient. A two-tailed Wilcoxon matched-pairs signed rank test was used to compare baseline and post-exercise peak levels of serum histamine (C) and tryptase (E) among individuals in the ISM patient cohort. **p=<0.01 *p=<0.05

References

    1. Carter MC, Metcalfe DD, Komarow HD . Mastocytosis. Immunol Allergy Clin North Am. 2014;34(1):181–96. - PMC - PubMed
    1. Metcalfe DD, Mekori YA. Pathogenesis and Pathology of Mastocytosis. Annu Rev Pathol. 2017;12:487–514. - PubMed
    1. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63(2):226–32. - PubMed
    1. Akin C, Metcalfe DD. Surrogate markers of disease in mastocytosis. Int Arch Allergy Immunol. 2002;127(2):133–6. - PubMed
    1. Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420–7. - PMC - PubMed

Publication types